Articles
After its reintroduction to the market, natalizumab was reserved for carefully selected patients under strict surveillance and for a limited period...
Multiple sclerosis (MS) is a chronic illness of the central nervous system affecting approximately 2.5 million young people worldwide.1 Regarded as...
Multiple sclerosis (MS) is a chronic illness of the central nervous system affecting approximately 2.5 million young people worldwide.1 Regarded as...
In this article we will present some features of these different dimensions and propose diagnostic and therapeutic cures, the latter (both...
"Many people have a false sense of security about these herbal products because they are seen as 'natural,'" said Arshad Jahangir, M.D.,...
Summary Cognitive deficits appear to be present in more than half of MS patients, however the majority of persons with MS do not have impairments...
Similar to MS, psoriasis is an autoimmune-mediated disorder. Fumaric acid esters (FAEs) have been used for the treatment of psoriasis in Europe for...
Similar to MS, psoriasis is an autoimmune-mediated disorder. Fumaric acid esters (FAEs) have been used for the treatment of psoriasis in Europe for...
Markers to Predict Disease Progression Magnetic Resonance Imaging as a Prognostic Marker MRI is a well established tool for the diagnosis4 and...
Overview of Multiple Sclerosis Course MS is widely regarded as an autoimmune disease, generally characterized by periodic relapses or...
We believe that the worldwide web has the potential to underpin global, comprehensive, long-term safety and efficacy outcome registries, and that...
Unfortunately, while all of these drugs represent advances for MS management, none is fully effective. The pivotal trials of all of these agents show...
The Extent of Cognitive Impairment in Multiple Sclerosis In his original characterisation of multiple sclerosis (MS), Jean Martin Charcot...
Prospective Randomised Trials The Independent Comparison of Interferon (INCOMIN) trial is the first prospective randomised directly comparative trial...
The inflammatory pathology of MS includes damage to the myelin and axon in the white matter of the brain and spinal cord.1 Recently, there have been...
Multiple Sclerosis Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system (CNS) that is characterised by...
Immunomodulators interferon-beta (IFNß) 1a-intramuscular (Avonex®);IFNß 1a-subcutaneous (Rebif®);IFNß 1b (Betaseron®);...
Patients with multiple sclerosis (MS) typically present with a clinically isolated syndrome (CIS), which eventually develops into relapsing–...
Overview of Multiple SclerosisCourseMS is widely regarded as an autoimmune disease, generally characterized by periodic relapses or exacerbations and...
Similarly, although we know the risk factors for poor prognosis – including a high relapse rate early in the disease course, being male, having...
